1
KLA CORP
COM NEW
KLAC
KLAC
178,471
$53.8m25.18%
25.18%
Reduced Shares held: Q3 2025 218.8k, Q4 2025 218.8k, Q1 2026 198.8k, Q2 2026 178.5k
-20.4k
-20,359
-10.2%
2
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
297,243
$17.1m8.01%
8.01%
Reduced Shares held: Q3 2025 316.8k, Q4 2025 302.8k, Q1 2026 306.3k, Q2 2026 297.2k
-9.0k
-9,025
-3.0%
3
LAM RESEARCH CORP
COM NEW
LRCX
LRCX
35,000
$15.2m7.09%
7.09%
Reduced Shares held: Q3 2025 0, Q4 2025 40.3k, Q1 2026 36.0k, Q2 2026 35.0k
-1.0k
-1,000
-2.8%
4
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
385,900
$6.8m3.17%
3.17%
Reduced Shares held: Q3 2025 60.0k, Q4 2025 315.4k, Q1 2026 445.4k, Q2 2026 385.9k
-59.5k
-59,500
-13.4%
5
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
666,196
$6.7m3.11%
3.11%
Added Shares held: Q3 2025 297.0k, Q4 2025 706.0k, Q1 2026 626.0k, Q2 2026 666.2k
+40.2k
+40,216
6.4%
6
BIODESIX INC
COM
COM
286,804
$6.5m3.02%
3.02%
Unchanged Shares held: Q3 2025 286.8k, Q4 2025 286.8k, Q1 2026 286.8k, Q2 2026 286.8k
7
STOKE THERAPEUTICS INC
COM
STOK
STOK
178,110
$5.8m2.73%
2.73%
Reduced Shares held: Q3 2025 210.0k, Q4 2025 260.0k, Q1 2026 210.0k, Q2 2026 178.1k
-31.9k
-31,890
-15.2%
8
OVINTIV INC
COM
OVV
OVV
107,500
$5.7m2.65%
2.65%
Unchanged Shares held: Q3 2025 107.5k, Q4 2025 107.5k, Q1 2026 107.5k, Q2 2026 107.5k
9
NEKTAR THERAPEUTICS
COM NEW
NKTR
NKTR
81,000
$5.7m2.64%
2.64%
Added Shares held: Q3 2025 4.0k, Q4 2025 31.0k, Q1 2026 31.0k, Q2 2026 81.0k
+50.0k
+50,000
161.3%
10
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
57,200
$5.0m2.33%
2.33%
Added Shares held: Q3 2025 67.2k, Q4 2025 67.2k, Q1 2026 47.2k, Q2 2026 57.2k
+10.0k
+10,000
21.2%
11
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
27,190
$4.6m2.14%
2.14%
Unchanged Shares held: Q3 2025 28.7k, Q4 2025 27.2k, Q1 2026 27.2k, Q2 2026 27.2k
12
PROTHENA CORP PLC
SHS
PRTA
PRTA
449,019
$4.4m2.06%
2.06%
Unchanged Shares held: Q3 2025 549.0k, Q4 2025 441.0k, Q1 2026 449.0k, Q2 2026 449.0k
13
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
171,000
$4.3m2.02%
2.02%
Unchanged Shares held: Q3 2025 171.0k, Q4 2025 171.0k, Q1 2026 171.0k, Q2 2026 171.0k
14
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
35,018
$4.3m2.01%
2.01%
Added Shares held: Q3 2025 48.0k, Q4 2025 55.0k, Q1 2026 35.0k, Q2 2026 35.0k
+18
+18
0.1%
15
COMPASS THERAPEUTICS INC
COM
CMPX
CMPX
1,675,000
$3.7m1.72%
1.72%
Added Shares held: Q3 2025 872.9k, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 1.7m
+209.1k
+209,133
14.3%
16
RELMADA THERAPEUTICS INC
COM
RLMD
RLMD
408,100
$2.8m1.32%
1.32%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 409.4k, Q2 2026 408.1k
-1.3k
-1,287
-0.3%
17
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$2.6m1.23%
1.23%
Unchanged Shares held: Q3 2025 50.0k, Q4 2025 50.0k, Q1 2026 50.0k, Q2 2026 50.0k
18
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
33,251
$2.6m1.22%
1.22%
Added Shares held: Q3 2025 10.1k, Q4 2025 10.1k, Q1 2026 10.1k, Q2 2026 33.3k
+23.2k
+23,151
229.2%
19
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
69,900
$2.6m1.22%
1.22%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 70.1k, Q2 2026 69.9k
-195
-195
-0.3%
20
CYTOKINETICS INC
COM NEW
CYTK
CYTK
30,000
$2.6m1.20%
1.20%
Unchanged Shares held: Q3 2025 30.0k, Q4 2025 30.0k, Q1 2026 30.0k, Q2 2026 30.0k
21
OLEMA PHARMACEUTICALS INC
COM
OLMA
OLMA
199,000
$2.5m1.16%
1.16%
Reduced Shares held: Q3 2025 174.0k, Q4 2025 269.0k, Q1 2026 219.0k, Q2 2026 199.0k
-20.0k
-20,000
-9.1%
22
VERA THERAPEUTICS INC
CL A
VERA
VERA
57,758
$2.5m1.16%
1.16%
Added Shares held: Q3 2025 0, Q4 2025 44.0k, Q1 2026 44.0k, Q2 2026 57.8k
+13.8k
+13,758
31.3%
23
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
4,506
$2.4m1.14%
1.14%
Added Shares held: Q3 2025 3.0k, Q4 2025 3.0k, Q1 2026 4.5k, Q2 2026 4.5k
+6
+6
0.1%
24
ZENAS BIOPHARMA INC
COM
ZBIO
ZBIO
93,601
$2.4m1.11%
1.11%
Added Shares held: Q3 2025 16.5k, Q4 2025 0, Q1 2026 70.0k, Q2 2026 93.6k
+23.6k
+23,601
33.7%
25
UNIQURE NV
SHS
QURE
QURE
50,697
$2.3m1.09%
1.09%
Reduced Shares held: Q3 2025 78.7k, Q4 2025 30.8k, Q1 2026 100.7k, Q2 2026 50.7k
-50.0k
-50,000
-49.6%
26
PACIFIC BIOSCIENCES CALIF IN
COM
PACB
PACB
1,350,000
$2.3m1.06%
1.06%
Reduced Shares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 1.5m, Q2 2026 1.4m
-150.0k
-150,000
-10.0%
27
ABIVAX SA
SPONSORED ADS
ABVX
ABVX
17,000
$2.3m1.06%
1.06%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 17.0k
28
VIR BIOTECHNOLOGY INC
COM
VIR
VIR
220,000
$2.2m1.05%
1.05%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 220.0k
29
BIOGEN INC
COM
BIIB
BIIB
9,000
$1.9m0.91%
0.91%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 5.0k, Q2 2026 9.0k
+4.0k
+4,000
80.0%
30
EQT CORP
COM
EQT
EQT
34,619
$1.8m0.86%
0.86%
Unchanged Shares held: Q3 2025 34.6k, Q4 2025 34.6k, Q1 2026 34.6k, Q2 2026 34.6k
31
BIOAGE LABS INC
COM
BIOA
BIOA
69,000
$1.7m0.79%
0.79%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 69.0k
32
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
29,000
$1.6m0.77%
0.77%
Reduced Shares held: Q3 2025 43.1k, Q4 2025 43.0k, Q1 2026 29.2k, Q2 2026 29.0k
-200
-200
-0.7%
33
QUIDEL CORP
COM
QDEL
QDEL
89,377
$1.6m0.73%
0.73%
Added Shares held: Q3 2025 72.5k, Q4 2025 72.5k, Q1 2026 82.5k, Q2 2026 89.4k
+6.8k
+6,829
8.3%
34
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
6,000
$1.5m0.69%
0.69%
Unchanged Shares held: Q3 2025 6.0k, Q4 2025 6.1k, Q1 2026 6.0k, Q2 2026 6.0k
35
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
281,937
$1.4m0.64%
0.64%
Added Shares held: Q3 2025 281.7k, Q4 2025 281.7k, Q1 2026 281.7k, Q2 2026 281.9k
+207
+207
0.1%
36
BICYCLE THERAPEUTICS PLC
SPONSORED ADS
BCYC
BCYC
313,616
$1.3m0.62%
0.62%
Reduced Shares held: Q3 2025 154.0k, Q4 2025 462.7k, Q1 2026 463.6k, Q2 2026 313.6k
-150.0k
-149,983
-32.4%
37
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
24,000
$1.3m0.60%
0.60%
Reduced Shares held: Q3 2025 78.0k, Q4 2025 90.0k, Q1 2026 100.0k, Q2 2026 24.0k
-76.0k
-76,000
-76.0%
38
XENON PHARMACEUTICALS INC
COM
XENE
XENE
21,032
$1.3m0.59%
0.59%
Added Shares held: Q3 2025 21.0k, Q4 2025 21.0k, Q1 2026 21.0k, Q2 2026 21.0k
+32
+32
0.1%
39
NOVO-NORDISK A S
ADR
NVO
NVO
24,000
$1.2m0.54%
0.54%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 24.0k
40
FREEPORT-MCMORAN INC
CL B
FCX
FCX
18,035
$1.1m0.53%
0.53%
Reduced Shares held: Q3 2025 18.0k, Q4 2025 18.0k, Q1 2026 18.0k, Q2 2026 18.0k
-5
-5
-0.0%
41
IMMUNOME INC
COM
IMNM
IMNM
50,000
$1.1m0.50%
0.50%
Unchanged Shares held: Q3 2025 105.0k, Q4 2025 130.0k, Q1 2026 50.0k, Q2 2026 50.0k
42
PHARVARIS N V
COM
PHVS
PHVS
29,847
$1.0m0.48%
0.48%
Unchanged Shares held: Q3 2025 14.8k, Q4 2025 29.8k, Q1 2026 29.8k, Q2 2026 29.8k
43
HARROW INC
COM
HROW
HROW
24,000
$1.0m0.48%
0.48%
Unchanged Shares held: Q3 2025 40.0k, Q4 2025 34.0k, Q1 2026 24.0k, Q2 2026 24.0k
44
ADAGENE INC
ADS
ADAG
ADAG
240,000
$1.0m0.47%
0.47%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 240.0k
45
DEFINIUM THERAPEUTICS INC
COM SHS
DFTX
DFTX
20,000
$940.8k0.44%
0.44%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
46
SILENCE THERAPEUTICS PLC
ADS
SLN
SLN
71,218
$782.0k0.37%
0.37%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 71.2k
47
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
8,741
$651.0k0.30%
0.30%
Added Shares held: Q3 2025 8.7k, Q4 2025 8.7k, Q1 2026 8.7k, Q2 2026 8.7k
+53
+53
0.6%
48
4D MOLECULAR THERAPEUTICS IN
COM
FDMT
FDMT
48,505
$645.1k0.30%
0.30%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 48.5k
49
UROGEN PHARMA LTD
COM
URGN
URGN
16,487
$606.7k0.28%
0.28%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 16.5k
50
PHATHOM PHARMACEUTICALS INC
COM
PHAT
PHAT
55,000
$596.8k0.28%
0.28%
Reduced Shares held: Q3 2025 85.0k, Q4 2025 195.0k, Q1 2026 195.0k, Q2 2026 55.0k
-140.0k
-140,000
-71.8%
51
CAMP4 THERAPEUTICS CORP
COM
CAMP
CAMP
120,000
$524.4k0.25%
0.25%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 120.0k
52
SAVARA INC
COM
SVRA
SVRA
80,000
$492.8k0.23%
0.23%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.0k
53
CANDEL THERAPEUTICS INC
COM
CADL
CADL
47,756
$491.9k0.23%
0.23%
Reduced Shares held: Q3 2025 60.0k, Q4 2025 60.0k, Q1 2026 60.0k, Q2 2026 47.8k
-12.2k
-12,244
-20.4%
54
ALTIMMUNE INC
COM NEW
ALT
ALT
152,681
$464.1k0.22%
0.22%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 152.7k
55
COMPASS PATHWAYS PLC
SPONSORED ADS
CMPS
CMPS
30,000
$424.5k0.20%
0.20%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 375.0k, Q2 2026 30.0k
-345.0k
-345,000
-92.0%
56
KARYOPHARM THERAPEUTICS INC
COM
COM
42,952
$419.6k0.20%
0.20%
Reduced Shares held: Q3 2025 28.0k, Q4 2025 0, Q1 2026 84.0k, Q2 2026 43.0k
-41.0k
-41,000
-48.8%
57
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
20,000
$364.2k0.17%
0.17%
Unchanged Shares held: Q3 2025 20.0k, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
58
TRINITY CAP INC
COM
TRIN
TRIN
20,000
$357.8k0.17%
0.17%
Unchanged Shares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
59
CAPRICOR THERAPEUTICS INC
COM NEW
CAPR
CAPR
14,352
$345.6k0.16%
0.16%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 14.4k
60
CASTLE BIOSCIENCES INC
COM
CSTL
CSTL
12,984
$309.7k0.14%
0.14%
Added Shares held: Q3 2025 110.6k, Q4 2025 80.6k, Q1 2026 12.9k, Q2 2026 13.0k
+84
+84
0.7%
61
INVIVYD INC
COM
IVVD
IVVD
342,275
$298.6k0.14%
0.14%
New Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 342.3k
62
GRACE THERAPEUTICS INC
COM
GRCE
GRCE
120,000
$272.4k0.13%
0.13%
Added Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 120.0k
+70.0k
+70,000
140.0%
63
KAYNE ANDERSON BDC INC
COM SHS
KBDC
KBDC
20,000
$270.6k0.13%
0.13%
Unchanged Shares held: Q3 2025 0, Q4 2025 20.0k, Q1 2026 20.0k, Q2 2026 20.0k
64
VOYAGER THERAPEUTICS INC
COM
VYGR
VYGR
75,147
$263.0k0.12%
0.12%
Added Shares held: Q3 2025 134.9k, Q4 2025 74.9k, Q1 2026 74.9k, Q2 2026 75.1k
+229
+229
0.3%
65
PULMONX CORP
COM
LUNG
LUNG
200,543
$260.7k0.12%
0.12%
Reduced Shares held: Q3 2025 0, Q4 2025 250.6k, Q1 2026 250.2k, Q2 2026 200.5k
-49.7k
-49,678
-19.9%
66
OCULAR THERAPEUTIX INC
COM
OCUL
OCUL
20,655
$202.8k0.09%
0.09%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 320.0k, Q2 2026 20.7k
-299.3k
-299,345
-93.5%
67
FIBROGEN INC
COM NEW
KYNB
KYNB
22,566
$170.4k0.08%
0.08%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 22.6k, Q2 2026 22.6k
68
ELUTIA INC
CL A COM
ELUT
ELUT
165,094
$161.7k0.08%
0.08%
Unchanged Shares held: Q3 2025 711.2k, Q4 2025 263.0k, Q1 2026 165.1k, Q2 2026 165.1k
69
QUOIN PHARMACEUTICALS LTD
SPONSORED ADS
QNRX
QNRX
20,000
$96.8k0.05%
0.05%
Unchanged Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 20.0k, Q2 2026 20.0k
70
LIPOCINE INC NEW
COM NEW
LPCN
LPCN
16,712
$42.8k0.02%
0.02%
Reduced Shares held: Q3 2025 0, Q4 2025 0, Q1 2026 111.8k, Q2 2026 16.7k
-95.1k
-95,074
-85.0%
71
DOCGO INC
COM
DCGO
DCGO
39,062
$20.2k0.01%
0.01%
Reduced Shares held: Q3 2025 764.1k, Q4 2025 49.9k, Q1 2026 39.6k, Q2 2026 39.1k
-511
-511
-1.3%
72
GOSSAMER BIO INC
COM
GOSS
GOSS
18,176
$3.0k0.00%
0.00%
Unchanged Shares held: Q3 2025 138.2k, Q4 2025 138.2k, Q1 2026 18.2k, Q2 2026 18.2k